• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体视网膜牵引自发松解的预测因素:系统评价和荟萃分析。

PREDICTIVE FACTORS OF SPONTANEOUS RELEASE OF VITREOMACULAR TRACTION: A Systematic Review and Meta-Analysis.

机构信息

Faculty of Medicine, University of Toronto, Toronto, Canada.

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada ; and.

出版信息

Retina. 2022 Jul 1;42(7):1219-1230. doi: 10.1097/IAE.0000000000003513.

DOI:10.1097/IAE.0000000000003513
PMID:35483036
Abstract

PURPOSE

To review predictive factors of spontaneous vitreomacular traction (VMT) release.

METHODS

A systematic literature search was performed on Ovid MEDLINE, Embase, and Cochrane Library. Studies comparing spontaneously released VMT to persistent VMT were included. A meta-analysis was performed using a random effects model, and weighted mean difference, risk ratio (RR), and 95% confidence intervals (95% CI) were reported as appropriate.

RESULTS

Of a search of 258 studies, 12 studies were included, from which 272 of 934 eyes (29%) underwent spontaneous release. Mean age was 70.0 years, 37.2% of patients were men, and mean follow-up was 22.0 months. Significant predictive factors for spontaneous release were smaller VMT diameter (n = 177; weighted mean difference = -212.48 µm, 95% CI = [-417.36, -7.60], P = 0.04), epiretinal membrane absence (n = 162; RR = 2.17, 95% CI = [1.18, 3.97], P = 0.01), and right eye involvement (n = 76; RR = 2.10, 95% CI = [1.14, 3.88], P = 0.02). Nonsignificant factors were age, initial best-corrected visual acuity, sex, ocular comorbidity, fellow-eye posterior vitreous detachment, previous intravitreal injection, and VMT classification with focal defined as ≤400 µm. Mean release time was 15.3 months (n = 212). Mean best-corrected visual acuity improved from 0.34 ± 0.21 (Snellen 20/44) to 0.20 ± 0.58 logMAR (Snellen 20/32) postrelease (n = 121).

CONCLUSION

Smaller VMT diameter, epiretinal membrane absence, and right eye involvement may support spontaneous VMT release. If patients have tolerable symptoms, clinicians may consider observation in patients with these predictive factors.

摘要

目的

回顾自发性玻璃体黄斑牵引(VMT)松解的预测因素。

方法

在 Ovid MEDLINE、Embase 和 Cochrane 图书馆进行系统文献检索。纳入比较自发性 VMT 松解与持续性 VMT 的研究。使用随机效应模型进行荟萃分析,并报告适当的加权均数差、风险比(RR)和 95%置信区间(95%CI)。

结果

在对 258 项研究进行检索后,纳入 12 项研究,其中 934 只眼中有 272 只(29%)发生自发性松解。平均年龄为 70.0 岁,37.2%的患者为男性,平均随访时间为 22.0 个月。自发性松解的显著预测因素为较小的 VMT 直径(n=177;加权均数差=-212.48 µm,95%CI=[-417.36,-7.60],P=0.04)、无视网膜内膜(n=162;RR=2.17,95%CI=[1.18,3.97],P=0.01)和右眼受累(n=76;RR=2.10,95%CI=[1.14,3.88],P=0.02)。无统计学意义的因素为年龄、初始最佳矫正视力、性别、眼部合并症、对侧眼后玻璃体脱离、既往玻璃体腔内注射和 VMT 分类,其中以局灶性定义为≤400 µm。平均松解时间为 15.3 个月(n=212)。121 例患者的最佳矫正视力从 0.34±0.21(Snellen 20/44)改善至 0.20±0.58 logMAR(Snellen 20/32)(n=121)。

结论

较小的 VMT 直径、无视网膜内膜和右眼受累可能支持自发性 VMT 松解。如果患者有可耐受的症状,临床医生可能会考虑在有这些预测因素的患者中进行观察。

相似文献

1
PREDICTIVE FACTORS OF SPONTANEOUS RELEASE OF VITREOMACULAR TRACTION: A Systematic Review and Meta-Analysis.玻璃体视网膜牵引自发松解的预测因素:系统评价和荟萃分析。
Retina. 2022 Jul 1;42(7):1219-1230. doi: 10.1097/IAE.0000000000003513.
2
Long-term evaluation of vitreomacular traction disorder in spectral-domain optical coherence tomography.频域光学相干断层扫描对玻璃体黄斑牵引综合征的长期评估。
Retina. 2011 Feb;31(2):324-31. doi: 10.1097/iae.0b013e3181eef08c.
3
Real-life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study.玻璃体内注射奥克纤溶酶治疗玻璃体黄斑牵引和黄斑裂孔的真实生活经验:一项频域光学相干断层扫描前瞻性研究。
Graefes Arch Clin Exp Ophthalmol. 2016 Feb;254(2):223-33. doi: 10.1007/s00417-015-3031-1. Epub 2015 May 5.
4
INTRAVITREAL SULFUR HEXAFLUORIDE INJECTION FOR THE TREATMENT OF VITREOMACULAR TRACTION SYNDROME.玻璃体内注射六氟化硫治疗玻璃体黄斑牵引综合征
Retina. 2016 Apr;36(4):733-7. doi: 10.1097/IAE.0000000000000760.
5
NATURAL COURSE OF VITREOMACULAR TRACTION IN EYES WITH DIABETIC RETINOPATHY AND FACTORS ASSOCIATED WITH SPONTANEOUS RELEASE.糖尿病性视网膜病变眼玻璃体牵引的自然病程及自发性松解的相关因素。
Retina. 2021 Aug 1;41(8):1668-1674. doi: 10.1097/IAE.0000000000003093.
6
Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography.使用频域光学相干断层扫描对玻璃体黄斑牵引和视网膜前膜进行三维评估。
Am J Ophthalmol. 2008 Mar;145(3):509-517. doi: 10.1016/j.ajo.2007.10.014. Epub 2008 Jan 11.
7
Idiopathic Vitreomacular Traction Managed with Initial Observation: Clinical Course and Outcomes.特发性玻璃黄斑牵引的初始观察管理:临床病程和结果。
Ophthalmol Retina. 2022 Oct;6(10):893-898. doi: 10.1016/j.oret.2022.04.021. Epub 2022 May 5.
8
Calculating the individual probability of successful ocriplasmin treatment in eyes with VMT syndrome: a multivariable prediction model from the EXPORT study.计算 VMT 综合征眼中 ocriplasmin 治疗成功的个体概率:来自 EXPORT 研究的多变量预测模型。
Br J Ophthalmol. 2018 Aug;102(8):1092-1097. doi: 10.1136/bjophthalmol-2017-310874. Epub 2017 Oct 31.
9
Short-term changes in posterior vitreous cortex following intravitreal ocriplasmin for symptomatic vitreomacular traction syndrome: a prospective study.玻璃体内注射奥克纤溶酶治疗症状性玻璃体黄斑牵拉综合征后玻璃体后皮质的短期变化:一项前瞻性研究
Int Ophthalmol. 2020 Jan;40(1):185-193. doi: 10.1007/s10792-019-01177-7. Epub 2019 Sep 29.
10
COMPARING INTRAVITREAL AIR AND GAS FOR THE TREATMENT OF VITREOMACULAR TRACTION.比较玻璃体内注气和注气治疗玻璃体牵引。
Retina. 2020 Nov;40(11):2140-2147. doi: 10.1097/IAE.0000000000002733.

引用本文的文献

1
[Current treatment strategies for vitreomacular traction and macular holes: a survey of retinal specialists in Germany].[玻璃体黄斑牵拉和黄斑裂孔的当前治疗策略:德国视网膜专家调查]
Ophthalmologie. 2024 Dec;121(12):973-984. doi: 10.1007/s00347-024-02118-1. Epub 2024 Sep 26.
2
[Vitreomacular traction: diagnostics, natural course, treatment decision and guideline recommendations].[玻璃体黄斑牵拉:诊断、自然病程、治疗决策及指南推荐]
Ophthalmologie. 2024 Jun;121(6):470-475. doi: 10.1007/s00347-024-02042-4. Epub 2024 May 29.